Page 1915 - Coronavirus

Jubilant Life, Cipla rally up to 6% on inking pact with Gilead Sciences

According to the statements issued by Jubilant Life and Cipla, both the firms will have the right to register, manufacture and sell Gilead's Remdesivir drug in 127 countries including India

Rs 20-trillion stimulus: How brokerages have interpreted the measures

Overall, the government's measures to undertake changes on land, labour and laws and to provide liquidity appear large and should support sentiment

Top 10 biz headlines: Rs 20 trn stimulus package, IIP fall and more

Here are the top 10 headlines of the day

Coronavirus LIVE: PM Modi bats for local products, confirms lockdown 4.0

Coronavirus India LIVE update: PM Modi addressed the nation tonight on lockdown extension. Stay tuned with Business Standard for Covid-19 LIVE updates on corona cases and death toll worldwide

Best of BS Opinion: Rs 20-trn stimulus, govt's borrowing plan, and more

Here's a selection of Business Standard opinion pieces of the day

Govt plans tax holiday for new investments amid Covid-19 outbreak

Another variant of the programme will be to provide a four-year tax holiday to firms that invest $100 million or more in labour-intensive sectors

PM Modi announces Rs 20 trillion stimulus package to jump-start economy

'Self-reliant India' package is around 10% of GDP; lockdown 4.0 is on with new guidelines

Nestle India PBT flat at Rs 704 cr for March quarter, revenue up 10.7%

The company follows a January-December accounting year. Revenue for the March quarter stood at Rs 3,325 crore, growth of 10.7 per cent from a year ago.

JPMorgan to raise up to $3 billion for real estate credit opportunity fund

JPMorgan Asset Management is looking to raise $2 billion to $3 billion from institutional investors for the Real Estate Credit Opportunity Fund, according to the source

Musk reopens Tesla's California plant against order, says ready for arrest

The move comes as states and cities around the United States experiment with ways to safely reopen their economies after the coronavirus outbreak shuttered businesses

Relief & fear: Migrants recall their struggle as railway services start

Many sustained on money sent by family for the last 50 days while some walked 5 hours to reach railway stations

Equity markets may cheer Rs 20-trn stimulus package; SGX Nifty jumps 5%

Following the announcement of a Rs 20-trn package, the Nifty contracts traded on the SGX shot up 5%, while the American depository receipts (ADR) of Indian companies gained between 3% and 10%.

Covid-19 impact on sectors: Consumption story hits the slow lane

The Rs 20-trillion stimulus package announced by the prime minister on Tuesday evening should help improve the fortunes of India Inc and these sectors

Haryana allows select firms to deploy 100% workforce in multiple shifts

Auto component major Sona Comstar, which earlier could deploy only half of its workers, has been allowed to bring in its entire workforce at its four plants - three in Gurugram and one in Manesar.

Iron ore prices likely to bounce back in H2FY21, expected to gain 15%

Recovery in domestic iron ore prices would be propelled by demand uptick as steel makers are expected to ramp up capacity utilisation with concerns easing on the Covid-19 pandemic

A day after, bond yield closes flat at 6.16% amid liquidity surplus

Given the plan to borrow an additional Rs 4.2 trillion from the market, yields will show a tendency to move up. But, the huge liquidity in the system kept the rise in check, bond dealers said.

Covid-19 crisis: Life insurers look to hedge against policy surrenders

As a remedy, life insurers are looking to provide short-term credit - known as bridge loans - to policyholders.

Tata Motors is worth nothing without Jaguar Land Rover, says CLSA

The $3.7 billion Indian auto firm faces a significant increase in debt due to the crisis, and its plan to deleverage may be delayed by four to six quarters, CLSA said.

Jubilant Life inks non-exclusive licensing pact with Gilead for Remdesivir

The drug, which is an injectable, got emergency approval from the US drug regulator recently.

Rs 20-trn package need of the hour, will unleash economic growth: India Inc

Industry bodies said the Make In India flagship will emerge as a key catalyst for attracting new investment, driven by much needed bold reforms in the areas of land, labour and liquidity